Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $148.00, giving the company a market capitalization of 365.49B. It carries a P/E multiple of 120.62 and pays a dividend yield of 2.23%.
On 2026-09-24, Merck(MRK) stock moved within a range of $146.89 to $151.52. With shares now at $148.00, the stock is trading +0.8% above its intraday low and -2.3% below the session's peak.
Trading volume for Merck(MRK) stock has reached 9.7M, versus its average volume of 11.03M.
The stock's 52-week range extends from a low of $77.58 to a high of $156.92.
The stock's 52-week range extends from a low of $77.58 to a high of $156.92.
MRK News
Merck (MRK) is back in focus after fresh regulatory milestones, including an FDA label update for WINREVAIR in pulmonary arterial hypertension and new approvals...
Analyst Jason Gerberry from Bank of America Securities maintained a Buy rating on Merck & Company and keeping the price target at $166.00. Jason Gerberry has gi...
Merck (MRK) announced the U.S. FDA has approved an update to the U.S. product label for Winrevair for injection, 45mg, 60mg, based on the Phase 3 HYPERION trial...
Analyst ratings
68%
of 31 ratingsMore MRK News
Merck (NYSE:MRK) received Japanese approval for KEYTRUDA QLEX, a subcutaneous version of its cancer therapy KEYTRUDA. The new formulation is designed for under...
Investing Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher A coveted Presidential Symposium slot at E...
Merck (MRK) has secured Japanese regulatory approval for KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) for subcutaneous injection, covering all...
Merck (MRK) announced the Ministry of Health, Labor and Welfare in Japan has approved Keytruda Qlex injection for subcutaneous use for all indications approved...
Investing Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story? Both Amgen and Merck write quarterly checks and raise them every year, but onl...
Moderna Inc. (NASDAQ:MRNA) shares are popping Thursday, extending a month-long rally that began with a Phase 3 cancer vaccine breakthrough. Moderna shares are...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.